| Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer (NCT06288620) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-25 |
| Diagnostic Performance of a Novel Ferumoxytol-Enhanced Magnetic Resonance Angiography/ Venography on Panvascular Disease (NCT06136806) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-23 |
| Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD) (NCT06225713) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-02 |
| Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (NCT06563869) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-02 |
| Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy (NCT06253091) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-01 |
| PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma (NCT06696742) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-01 |
| Effect of Vericiguat on Acute Coronary Syndrome( ACS）Patients With Ejection Fraction <45% (NCT06321094) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-31 |
| A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries (NCT07400406) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-26 |
| Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP (NCT06231004) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-22 |
| Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT06208462) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-19 |
| First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer (NCT06375707) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-09 |
| Adult Idiopathic Inflammatory Myopathy With Cardiac Injury (NCT05982041) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study (NCT07446452) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study (NCT07065435) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study (NCT06254690) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy (NCT06241651) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML (NCT06232694) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm (NCT06015477) | The First Affiliated Hospital with Nanjing Medical University | 2024-01-01 |
| Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis (NCT05700266) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-30 |
| Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS) (NCT06080256) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-30 |
| NALIRIFOX as Induction Therapy in LAPC (NCT06467565) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-25 |
| Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal (NCT06244277) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-22 |
| Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC (NCT06153368) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-19 |
| Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC (NCT06177015) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-11 |
| A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE) (NCT06348407) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-01 |
| Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age (NCT06354218) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-01 |
| Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases (NCT06124729) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-01 |
| Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer (NCT06341894) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-17 |
| Safety and Efficacy of High-Intensity Macrofocused Ultrasound for Solar Lentigo in Chinese Population (NCT06288607) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-16 |
| Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial) (NCT06125925) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-06 |
| A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus (NCT06146751) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-06 |
| Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC. (NCT06060704) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-01 |
| Connective Tissue Disease Patients With Pulmonary Hypertension (NCT05980728) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-01 |
| A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer (NCT06001086) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-01 |
| Chi-GVM Regimen for the Treatment of R/R PTCL (NCT06211881) | The First Affiliated Hospital with Nanjing Medical University | 2023-10-25 |
| Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail (NCT06108596) | The First Affiliated Hospital with Nanjing Medical University | 2023-10-21 |
| Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease (NCT06588231) | The First Affiliated Hospital with Nanjing Medical University | 2023-10-17 |
| Study on the Thrombolytic Effect of Platelet Membrane Coated Recombinant Staphylokinase on Human Arterial Thrombus (NCT05978791) | The First Affiliated Hospital with Nanjing Medical University | 2023-10-11 |
| Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer (NCT06360471) | The First Affiliated Hospital with Nanjing Medical University | 2023-10-01 |
| Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC (NCT06037655) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-25 |
| A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD (NCT06061627) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-21 |
| Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion (NCT06542653) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-17 |
| Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study (NCT06052020) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-15 |
| Omission of ALND in Breast Cancer Patients With Axillary pCR (NCT05939830) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-11 |
| Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II) (NCT06018493) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-01 |
| An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL (NCT06015464) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-01 |
| Medical Tai Chi Exercise Healing in Treating mCRC Patients (NCT06104267) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-01 |
| Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients (NCT06467851) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-31 |
| Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma (NCT06010212) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-25 |
| Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients (NCT05974449) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-24 |
| The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE (NCT06041425) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-07 |
| Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position (NCT06572501) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-06 |
| Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC (NCT05983783) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-01 |
| The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Anxiety in PD (NCT05950347) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-01 |
| High Resolution Diffusion Weighted Imaging in Prostate (NCT06636747) | The First Affiliated Hospital with Nanjing Medical University | 2023-08-01 |
| Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer (NCT05772377) | The First Affiliated Hospital with Nanjing Medical University | 2023-07-01 |
| The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection (NCT06287541) | The First Affiliated Hospital with Nanjing Medical University | 2023-07-01 |
| Omission of SLNB in CN0 Early Breast Cancer (NCT05935150) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-21 |
| Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC (NCT05956639) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-20 |
| Effect of HIIT on Cardiopulmonary Function After PCI in Patients With Coronary Heart Disease (NCT06575569) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-17 |
| Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy (NCT06125834) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
| A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL (NCT05931263) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
| Application of Brachial Plexus Block in Patients Undergoing Cerebral Aneurysm Embolization Via Transradial Approach (NCT06035692) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
| A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (NCT05896800) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
| Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot (NCT05999656) | The First Affiliated Hospital with Nanjing Medical University | 2023-05-28 |
| Transradial Access for Ruptured Intracranial Aneurysms Embolization (NCT05851274) | The First Affiliated Hospital with Nanjing Medical University | 2023-05-10 |
| Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention (NCT06463808) | The First Affiliated Hospital with Nanjing Medical University | 2023-05-03 |
| Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer (NCT05808582) | The First Affiliated Hospital with Nanjing Medical University | 2023-05-01 |
| Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm (NCT05749393) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-30 |
| Association Between Body Composition and Digestive System Cancer Survival (NCT06054685) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-17 |
| Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS) (NCT05741086) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-15 |
| Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer (NCT05430347) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-15 |
| R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05784987) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-15 |
| Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission (NCT05909293) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-12 |
| Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer (NCT05834582) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-08 |
| Pyrotinib in Women With High-risk in Early Stage Breast Cancer (NCT05834764) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-08 |
| Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction (NCT05410925) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-08 |
| Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma (NCT05774028) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-01 |
| A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide. (NCT05967949) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-01 |
| Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL) (NCT05772728) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-01 |
| R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma (NCT05777369) | The First Affiliated Hospital with Nanjing Medical University | 2023-03-01 |
| CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (NCT05896813) | The First Affiliated Hospital with Nanjing Medical University | 2023-03-01 |
| Viable Myocardium Detected by Hybrid PET/MR and SPECT for the Prediction of the Efficacy of PCI in Patients With CTO. (NCT06113835) | The First Affiliated Hospital with Nanjing Medical University | 2023-02-22 |
| Bp-MRI Based Multi-planar VI-RADS (NCT06607250) | The First Affiliated Hospital with Nanjing Medical University | 2023-02-20 |
| Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma (NCT05613478) | The First Affiliated Hospital with Nanjing Medical University | 2023-01-31 |
| The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens (NCT07035535) | The First Affiliated Hospital with Nanjing Medical University | 2023-01-01 |
| DNA Methylation Combined With Artificial Intelligence Imaging to Identify Lung Nodules (NCT06220305) | The First Affiliated Hospital with Nanjing Medical University | 2022-12-01 |
| Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC (NCT05534113) | The First Affiliated Hospital with Nanjing Medical University | 2022-12-01 |
| Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer (NCT05659056) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-29 |
| Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) (NCT05394623) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-01 |
| Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN (NCT05817955) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-01 |
| The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients. (NCT05931328) | The First Affiliated Hospital with Nanjing Medical University | 2022-10-15 |
| LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB (NCT05572957) | The First Affiliated Hospital with Nanjing Medical University | 2022-10-14 |
| A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. (NCT05594381) | The First Affiliated Hospital with Nanjing Medical University | 2022-10-01 |
| To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer (NCT05491694) | The First Affiliated Hospital with Nanjing Medical University | 2022-09-01 |
| Curative Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Disorders of PD (NCT05806736) | The First Affiliated Hospital with Nanjing Medical University | 2022-09-01 |
| Artificial Intelligence-Based Computer-Aided Diagnosis of Prostate Cancer (NCT05513638) | The First Affiliated Hospital with Nanjing Medical University | 2022-08-22 |
| Safety and Efficacy of Esketamine Combined With Dexmedetomidine for Sedation of Mechanically Ventilated Patients (NCT05466708) | The First Affiliated Hospital with Nanjing Medical University | 2022-08-11 |
| Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer (NCT05493683) | The First Affiliated Hospital with Nanjing Medical University | 2022-08-01 |
| The Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Impairments in PD (NCT05561348) | The First Affiliated Hospital with Nanjing Medical University | 2022-08-01 |